Health Condition 1: L745- Focal hyperhidrosis Health Condition 2: O- Medical and Surgical
Conditions
Interventions
Intervention1: Ultrasound-guided stellate ganglion intervention: Patients with primary palmar hyperhidrosis who have failed conservative treatment and fulfil the eligibility criteria will undergo an u
Sponsors
AIIMS Gorakhpur
Eligibility
Inclusion criteria
Inclusion criteria: Patients of either gender aged 18 to 60 years with clinically diagnosed primary palmar hyperhidrosis. Patients with Hyperhidrosis Disease Severity Scale score of 3 or more. Patients who have failed conservative treatment and are willing to undergo ultrasound-guided stellate ganglion intervention. Patients willing to provide written informed consent and comply with the scheduled follow-up visits.
Exclusion criteria
Exclusion criteria: Patients with coagulopathy or receiving anticoagulant therapy. Patients with local infection at the injection site. Patients with known allergy to lidocaine, dexamethasone or any drug used during the procedure. Patients with significant cardiopulmonary disease or an unstable medical condition. Pregnant or lactating women. Patients with secondary hyperhidrosis due to an underlying disease or medication. Patients unwilling to participate or unable to comply with the scheduled follow-up assessments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Hyperhidrosis Disease Severity Scale score following ultrasound-guided stellate ganglion intervention.Timepoint: Baseline, 1 week and 3 months after intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of patients achieving clinically significant improvement defined as at least a 2-point reduction in Hyperhidrosis Disease Severity Scale score.Timepoint: At 1 week and 3 months after intervention.;Change in Dermatology Life Quality Index score following stellate ganglion intervention.Timepoint: Baseline, 1 week and 3 months after intervention.;Duration of symptom relief and recurrence of significant palmar sweating following intervention.Timepoint: Assessed during follow-up up to 3 months after intervention | — |
Countries
India
Contacts
Public ContactAjay
AIIMS Gorakhpur
Outcome results
None listed